IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2024 Holdings

Filed 2024-11-14 | 10 holdings | $402.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$140.5M7,277,00034.9%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$67.5M16,390,00016.8%
Gilead Sciences Inc(GILD)COM375558103$64.0M763,33315.9%
Cytokinetics Inc(CYTK)COM NEW23282W605$58.6M1,110,00014.6%
Neurocrine Biosciences Inc(NBIX)COM64125C109$47.3M410,48311.8%
Amarin Corp PLCSPONS ADR NEW023111206$15.6M24,850,6233.9%
Biogen Inc(BIIB)COM09062X103$5.2M26,9501.3%
Lantheus Hldgs Inc(LNTH)COM516544103$2.9M26,0000.7%
VOR Biopharma IncCOM929033108$432.6K618,0000.1%
Regulus Therapeutics Inc(RGLS)COM75915K309$290.7K185,1830.1%